The Hannover Medical School (MHH) invites proposals for a
Georg Lichtenberg professorship (W2) application in bioinformatics and statistical genome research.

The appointment will be in close cooperation to the Research Core Unit “Next Generation Sequencing” (http://www.mh-hannover.de/ngs.html) at the MHH. It is planned to build a CentralCore Unit “Bioinformatics and Nucleic Acid Analysis” where the applicant should participate.The successful applicant has an excellent record of publications and academic achievements instatistical genome research and bioinformatics, particularly in the analysis of data from variousnext generation sequencing platforms and applications. Pertinent experience with programminglanguages (e.g. Perl, Java) is expected.

If accepted by the Volkswagenstiftung, the applicant will be funded for 5 years with a GeorgLichtenberg professorship. A tenure at the MHH is intended after an evaluation at the end of thisfunding period.

As the aim of the Georg Lichtenberg professorship stipend is to support outstandingly qualifiedyoung researchers, the applicants’ doctorate should have been obtained within the past sevenyears. For further details please refer to:http://www.volkswagenstiftung.de/nc/en/lichtenberg-professorships.html

Applicants are requested to send a concept of a highly innovative, cutting-edge research projectto be realized within the scope of the Stipend (maximum of 1000 words), supplemented by a fullCV and a complete list of publications by November 15th, 2015 toDiese E-Mail-Adresse ist vor Spambots geschützt! Zur Anzeige muss JavaScript eingeschaltet sein!

After an internal evaluation at the MHH, ending January 18th 2016, the successful applicant willbe asked to submit (in cooperation with the MHH) a final application with his envisagedresearch project until June 1st 2016 to the Volkswagenstiftung.The Hannover Medical School encourages applications from women. Severely handicappedapplicants with identical qualifications will be given priority consideration.

As representative for the Research Core Unit “Next Generation Sequencing”

Prof. Dr. Thomas Illig
CEO and Head of Hannover Unified Biobank (HUB)
Hannover Medical School (MHH), OE 9160